1

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis

mmnwsxujcb8a1j
Daniela Pugliese. Carla Felice. Rosario Landi. Alfredo Papa. https://www.missouriquiltcoes.shop/product-category/block/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story